Shares of Mark Zuckerberg's company, Meta Platforms (META.US), are gaining slightly today ahead of the fourth quarter results the company will report after the US trading session. Investors will pay attention to how the company's massive investment in artificial intelligence has affected its profitability from advertising. The market is also likely to be listening to whether 'concerns' about DeepSeek's effectiveness will cause the company to cast doubt on its recently announced massive AI CAPEX of $65 billion. The company's stock is up nearly 45% in 2024 and nearly 650% from its 2022 lows. As a result, any 'stumble' in the report could trigger profit-taking.
Wall Street expectations
-
Revenue between $45-48 billion, up 17% year-over-year.
- Earnings per share (EPS) of $6.75, a 27% increase over Q4 2023.
These results will be analyzed in the context of Meta's plans for capital expenditures (capex) in the range of $60-65 billion in 2025, most of which will be spent on AI infrastructure development. At the same time, the market will pay attention to potential competition from DeepSeek. Digital advertising will continue to be the dominant source of revenue, accounting for 98% of total sales. The question is how much it will be accelerated by new AI tools and higher ad prices.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appIn the last quarter, the number of Meta ad impressions increased by 7% y/y and the average price by 11% y/y. A continuation of this momentum, with still impressive growth in the number of active app users (Facebook, WhatsApp, Instagram; 5% y/y growth in Q3 to 3.29 billion users) could translate into improved sentiment around the company's stock.
CAPEX on AI and EU legal suits
-
A potential CAPEX warning for 2025 could involve a drop in sentiment around a number of AI-related companies such as Nvidia (NVDA.US), and Arista Networks (ANET.US). On the other hand, if the company leaves CAPEX unchanged, the market may take this as 'good coin' and consider the reaction to DeepSeek as completely unjustified and not a 'game changer' in the technology market.
- Ultimately, the company may also benefit from Donald Trump, who indicated in Davos that the penalties the European Union intends to impose on US BigTech, including Meta, will be met with criticism from the US administration. Investors can expect communication in this regard as well, although it is highly uncertain that Meta will make any declarations in this regard.
-
Investors expect Meta to guide for 2025 CAPEX of about $52 billion, a 31% increase from the possible $39 billion in 2024. The consensus 2025 CAPEX estimates from analysts have increased 9% since Q3 2024 earnings release in October 2024 and 42% from a year ago. Any surprise regarding 2025 capex guidance may impact shares, but the reason behind the guidance will be very important.
-
For example, lower AI infrastructure spending may even boost the company earnings, if AI will contribute to profitability positively. On the other hand, weaker net results and falling CAPEX may signal that the company is set to analyse its AI strategy again.
Meta Platforms (META.US)
Meta Platforms' stock has been on a powerful upswing spurred by earnings expansion, reduced operating costs and an additional catalyst in the form of artificial intelligence, the positive impact of which on the advertising market is 'quickly apparent' business-wise (better personalization of content and efficient analysis of user data). The options market, as probable indicates about 7% price change after today's financial results. Based on this assumption, a test of both $620 and $715 is realistic.
Source: xStation5
Meta Platforms' multiple valuation is roughly in line with the average of companies in the Nasdaq 100 index, and the forward P/E is clearly below the current P/E (price/earnings) ratio. Investors expect strong profitability growth from the company and will analyze today's results from this perspective.
Source: XTB Research, Bloomberg Finance L.P.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.